亚洲 · 区域市场 · Business Standard
Dr Reddy's share price spurts 4% post Q2 earnings; analysts upgrade rating
Analysts at Systematix Institutional Research and Elara Securities upgraded rating on Dr Reddy's Laboratories stock from 'Hold' to 'Buy' and 'Reduce' to 'Accumulate', respectively.
在 Business Standard 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.business-standard.com)
